Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32073956

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Apr 10
First author
Penson RT

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2020 Aug 10;38(23):2698. doi: 10.1200/JCO.20.01235.
    note
    Source null
    related pmid
    32530766
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2020 Aug 10;38(23):2697-2698. doi: 10.1200/JCO.20.00576.
    note
    Source null
    related pmid
    32530768
    relationship
    Comment in

Authors and identifiers

  1. name
    Penson RT
    type
    Author
  2. name
    Valencia RV
    type
    Author
  3. name
    Cibula D
    type
    Author
  4. name
    Colombo N
    type
    Author
  5. name
    Leath CA 3rd
    type
    Author
  6. name
    Bidziński M
    type
    Author
  7. name
    Kim JW
    type
    Author
  8. name
    Nam JH
    type
    Author
  9. name
    Madry R
    type
    Author
  10. name
    Hernández C
    type
    Author
  11. name
    Mora PAR
    type
    Author
  12. name
    Ryu SY
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Penson RT
    type
    Author
  2. name
    Valencia RV
    type
    Author
  3. name
    Cibula D
    type
    Author
  4. name
    Colombo N
    type
    Author
  5. name
    Leath CA 3rd
    type
    Author
  6. name
    Bidziński M
    type
    Author
  7. name
    Kim JW
    type
    Author
  8. name
    Nam JH
    type
    Author
  9. name
    Madry R
    type
    Author
  10. name
    Hernández C
    type
    Author
  11. name
    Mora PAR
    type
    Author
  12. name
    Ryu SY
    type
    Author
bibliography ids
  1. nci-bib-8ee9c7a1917772d0a5972204
book metadata
content sha256
4ab58900bae13e0e41c96b0e10896806fed3583f00fe9c0f59de33f587d63854
document type
citation
dois
  1. 10.1200/JCO.19.02745
electronic publication date
display
2020 Feb 19
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32073956
immutable id
pubmed:32073956@4ab58900bae13e0e41c96b0e10896806fed3583f00fe9c0f59de33f587d63854
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
11
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1164-1174
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2020 Aug 10;38(23):2698. doi: 10.1200/JCO.20.01235.
    note
    Source null
    related pmid
    32530766
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2020 Aug 10;38(23):2697-2698. doi: 10.1200/JCO.20.00576.
    note
    Source null
    related pmid
    32530768
    relationship
    Comment in
outcomes validated
false
pmid
32073956
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
c45f7b0e101e7b140f95ee339082a01f8dfe8ed77ca7d4d98156f67eaccdbf65
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Apr 10
precision
day
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32073956/
title
Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial.

Preserved source evidence · Not medical advice